JUN 09, 2015 02:00 PM PDT

Implementation of MALDI-TOF Technology in Clinical Microbiology

Speakers
  • Technical Director, ACL Laboratories
    Biography
      Dr. Costello received his MT(ASCP) in 1973 and worked as a Medical Technologist in Hematology, Immunology and Microbiology and decided to return to graduate school in 1977. He received his Ph.D. in Immunology/Microbiology from Rush University, Chicago, IL. in 1982. He then moved to Lutheran General Hospital, Park ridge IL. in 1982 after receiving his Ph.D. After that he became Associate Director of the Advocate Consolidated Microbiology Laboratory in 1997 and was appointed Technical Director of ACL Microbiology Laboratories in 2003.

      Dr. Costello's interests are in rapid microbiological techniques including rapid viral diagnosis and rapid methods in Bacteriology.

    Abstract:
    The practice of laboratory clinical microbiology is finally changing driven by the assimilation of newer technologies, like Matrix Assisted Laser Desorption Ionization - Time of Flight/Mass Spectrometry or MALDI-TOF/MS, that performs reliable microbial identifications faster, better, and at reduced cost than traditional methods. Utilization of MALDI-TOF/MS can simplify workflow in the clinical Microbiology Laboratory while generating faster, consistent, and definitive identifications resulting in a positive impact on antibiotic stewardship, lessen spread of nosocomial pathogens, and result in improved directed care for the patient. However, like all technologies, MALDI-TOF is not perfect and the clinical microbiologist must understand and appreciate both the benefits and limitations of this new tool for identification of microbial pathogens. Measurement of successful implementation of this technology must include defined parameters to measure the effect on patient care and input from all involved parties including the medical staff, Pharmacy and Infection Control.

    Show Resources
    You May Also Like
    OCT 02, 2019 11:00 AM PDT
    OCT 02, 2019 11:00 AM PDT
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    JUN 05, 2019 05:00 PM CEST
    C.E. CREDITS
    JUN 05, 2019 05:00 PM CEST
    DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    MAY 21, 2019 07:00 AM PDT
    C.E. CREDITS
    MAY 21, 2019 07:00 AM PDT
    DATE: May 21, 2019TIMEL 7:00am PT, 10:00am ET Human T cells are central effectors of immunity and cancer immunotherapy. CRISPR-based functional studies in T cells could prioriti...
    JUN 18, 2019 04:00 PM CEST
    C.E. CREDITS
    JUN 18, 2019 04:00 PM CEST
    DATE: June 18, 2019TIME: 7:00am PDT, 10:00 EDT, 4:00pm CET PSCs represent an important tool in a wide range of applications, including basic research, disease modeling, drug...
    Loading Comments...
    Show Resources